Vietnam
· Delayed Price · Currency is VND OPC Pharmaceutical JSC Statistics
Total Valuation
OPC Pharmaceutical JSC has a market cap or net worth of VND 1.51 trillion. The enterprise value is 1.34 trillion.
| Market Cap | 1.51T |
| Enterprise Value | 1.34T |
Important Dates
The next estimated earnings date is Friday, January 24, 2025.
| Earnings Date | Jan 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OPC Pharmaceutical JSC has 64.05 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 64.05M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 13.94% |
| Owned by Institutions (%) | 13.40% |
| Float | 55.12M |
Valuation Ratios
The trailing PE ratio is 17.58.
| PE Ratio | 17.58 |
| Forward PE | n/a |
| PS Ratio | 1.59 |
| PB Ratio | 1.93 |
| P/TBV Ratio | 2.13 |
| P/FCF Ratio | 15.27 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.81, with an EV/FCF ratio of 13.52.
| EV / Earnings | 15.56 |
| EV / Sales | 1.41 |
| EV / EBITDA | 8.81 |
| EV / EBIT | 10.32 |
| EV / FCF | 13.52 |
Financial Position
The company has a current ratio of 2.74
| Current Ratio | 2.74 |
| Quick Ratio | 1.46 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 12.00% and return on invested capital (ROIC) is 9.39%.
| Return on Equity (ROE) | 12.00% |
| Return on Assets (ROA) | 6.85% |
| Return on Capital (ROIC) | 9.39% |
| Revenue Per Employee | 1.05B |
| Profits Per Employee | 95.41M |
| Employee Count | 926 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 1.31 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.64% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +0.64% |
| 50-Day Moving Average | 23,404.00 |
| 200-Day Moving Average | 23,801.00 |
| Relative Strength Index (RSI) | 57.25 |
| Average Volume (20 Days) | 377,924 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OPC Pharmaceutical JSC had revenue of VND 951.23 billion and earned 86.16 billion in profits. Earnings per share was 1,345.00.
| Revenue | 951.23B |
| Gross Profit | 453.23B |
| Operating Income | 128.34B |
| Pretax Income | 130.15B |
| Net Income | 86.16B |
| EBITDA | 150.63B |
| EBIT | 128.34B |
| Earnings Per Share (EPS) | 1,345.00 |
Balance Sheet
| Cash & Cash Equivalents | 237.77B |
| Total Debt | n/a |
| Net Cash | 237.77B |
| Net Cash Per Share | 3,712.23 |
| Equity (Book Value) | 847.72B |
| Book Value Per Share | 12,237.01 |
| Working Capital | 531.26B |
Cash Flow
In the last 12 months, operating cash flow was 109.57 billion and capital expenditures -10.38 billion, giving a free cash flow of 99.19 billion.
| Operating Cash Flow | 109.57B |
| Capital Expenditures | -10.38B |
| Free Cash Flow | 99.19B |
| FCF Per Share | 1,548.62 |
Margins
Gross margin is 47.65%, with operating and profit margins of 13.49% and 10.63%.
| Gross Margin | 47.65% |
| Operating Margin | 13.49% |
| Pretax Margin | 13.68% |
| Profit Margin | 10.63% |
| EBITDA Margin | 15.84% |
| EBIT Margin | 13.49% |
| FCF Margin | 10.43% |
Dividends & Yields
This stock pays an annual dividend of 1,500.00, which amounts to a dividend yield of 6.34%.
| Dividend Per Share | 1,500.00 |
| Dividend Yield | 6.34% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 94.92% |
| Buyback Yield | n/a |
| Shareholder Yield | 6.34% |
| Earnings Yield | 5.69% |
| FCF Yield | 6.55% |
Stock Splits
The last stock split was on July 21, 2022. It was a forward split with a ratio of 2.41.
| Last Split Date | Jul 21, 2022 |
| Split Type | Forward |
| Split Ratio | 2.41 |
Scores
OPC Pharmaceutical JSC has an Altman Z-Score of 4.83.
| Altman Z-Score | 4.83 |
| Piotroski F-Score | n/a |